U.S. Office — Brooklyn, NY · Mon–Fri 9:00–18:00 ET
Direct: +1 (347) 567-0781 · Email: info@sucotondusa.com
ProductsAboutCertificationsVerify FactoryBlogContact
Custom Development · Private Label

Carry elemental iron and the warning decision through the entire project.

Sucotond USA coordinates non-confidential feasibility review for U.S. brands planning custom iron gummies. The project file connects the exact iron salt and composition basis to elemental iron per serving, matrix interactions, assay, intended market, required warning review, package and stability evidence.

This is a custom-project service page, not a claim that one stocked salt, formula, dose, warning layout, package or shelf life fits every project.

Gummy manufacturing equipment inside the production facilityControl Points
Salt identitySupplier material and composition
Declared nutrientElemental iron per serving
Matrix behaviorTaste, color and interactions
Warning review21 CFR 101.17(e)
Package/stabilityApproved product-package system
Commercial termsConfirmed after feasibility
Current service status: open for non-confidential custom-project review. This page does not identify an approved Sucotond iron material, formula, label or package. The responsible firm retains final regulatory, claim and artwork approval.
Four Linked Risks

Iron is not just an ingredient-name field

Salt versus element

Keep total compound input separate from elemental iron and its controlled composition basis.

Matrix interaction

Review taste, color, acid system, co-ingredients, processing and storage together.

Warning and audience

Record intended population, market, warning applicability, placement and artwork owner.

Package over time

Connect the commercial closure and conditions to stability attributes and change control.

Claims boundary: this page makes no anemia, pregnancy, energy, absorption, disease, safety or efficacy claim. It does not provide legal advice, promise child-resistant packaging, identify an approved warning exception or establish a Sucotond test result.
Before a Quote

Eight decisions belong in the iron project file

1. Name the iron salt

  • Exact compound, supplier and grade
  • Physical form and composition basis
  • Incoming identity/document plan

2. State elemental iron

  • Amount per serving and units
  • Gummies per serving and piece mass
  • Formula tolerances and label basis

3. Define the user and market

  • Intended population and use direction
  • U.S. or other destination market
  • Responsible regulatory reviewer

4. Map matrix interactions

  • Base, acids, flavors, colors and sweeteners
  • Co-ingredients and excluded inputs
  • Sensory, appearance and process questions

5. Build the assay plan

  • Ingredient composition and finished analyte
  • Method, matrix, units and sampling
  • Specification and decision rule

6. Review the warning

  • 21 CFR 101.17(e) applicability
  • Exact approved text and placement
  • Immediate container and retail-package review

7. Approve the package

  • Bottle, closure, count and labeling panels
  • Distribution/storage assumptions
  • Stability protocol and change control

8. Define commercial scope

  • Development or commercial stage
  • Volume, timing and destination
  • Required documents and disclosure rights
Release Matrix

One traceable chain from salt to shelf

ControlRequired recordRelease question
MaterialSalt, supplier, grade, lot and elemental compositionIs this the approved and identified input?
FormulaCompound input, elemental target, serving and tolerancesDoes the batch match the controlled formula?
Finished testAnalyte, method, gummy matrix, units and samplingDoes evidence answer the label/specification question?
ArtworkSupplement Facts, other ingredients, warning and claimsWas the approved formula reconciled to the final label?
PackageImmediate container, retail pack, closure and countAre warning placement and package decisions complete?
StabilityCommercial product-package, conditions, attributes and timesDoes the evidence support the assigned dating decision?
Regulatory Context

Iron requires a visible label-control decision

Salt weight and elemental iron differ

The NIH Office of Dietary Supplements describes common ferrous and ferric supplement forms and notes that salts differ in elemental-iron proportion. Supplement Facts declares elemental iron. This reference frames the specification; it does not confirm a Sucotond material or result.

NIH ODS: Iron — Health Professional Fact Sheet

Read 21 CFR 101.17(e) directly

The current rule addresses solid oral dietary supplements containing iron or iron salts for use as an iron source. It prescribes an accidental-overdose warning and placement requirements. The actual formula, immediate container, retail package and labeling must be reviewed before approval.

21 CFR 101.17(e) — Iron warning

Buyer FAQ

Iron gummy project questions

Is iron-salt weight the same as elemental iron?

No. Connect the named salt and controlled composition basis to the intended elemental amount, assay and label.

Does an iron gummy need a U.S. accidental-overdose warning?

21 CFR 101.17(e) addresses solid oral iron supplements and prescribes warning text and placement. Final applicability and artwork require review of the actual product and package.

Which iron form is best for gummies?

There is no universal answer. Salt, load, taste, color, interactions, audience, method, label and package must be reviewed together.

Is child-resistant packaging guaranteed?

No. This page makes no package claim; the responsible team must review the actual product, applicable requirements and market.

What belongs in the RFQ?

Include iron source, elemental target, serving, audience and market, matrix, evidence, warning review, package, volume stage and timing.

Non-Confidential Project Intake

Request an iron gummy feasibility map

Share the salt and elemental target, intended population and market, serving, matrix, test plan, warning and package review, volume stage and timing. The review identifies open questions; it is not legal advice, a formula, quote, result or production commitment.

Sucotond USA

U.S. sales and project coordination

Address7624 17th Ave
Brooklyn, NY 11214

Do not submit confidential formula details before an NDA is in place. By submitting, you agree that Sucotond USA may use these details to evaluate and respond to the inquiry. Privacy notice.

Thanks — your brief was received.
The project inputs are ready for internal review.
Related Micronutrient Programs

Keep elemental amount, matrix and label decisions separate

Compare the project file for elemental calcium and compound composition, vitamin C source and stability design, and custom vitamin D3 plus K2 gummy formulation. Use the gummy label and artwork approval checklist before approving warning or nutrient statements.